JENKINS DAVID A 4

What Happened David A. Jenkins, Chairman and CEO of Catheter Precision, was the recipient of a derivative award covering 40,000 shares on 2026-03-26. The Form 4 shows an acquisition categorized as an award/grant (derivative) at $0.00 — meaning no cash was paid at the time of grant. Footnotes indicate these are options that vest 100% on the 180-day anniversary of the grant date.

Key Details

• Transaction date: 2026-03-26; Form filed: 2026-03-30.
• Transaction type: Award/derivative grant of 40,000 shares (options), reported at $0.00 (no cash paid at grant).
• Vesting: 100% vests on the 180-day anniversary of grant (per footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Filing date is shown; no late-filing flag (transactionTimeliness = 'L') was provided in the supplied data.

Context

• This was a grant of derivative securities (options) rather than an open-market purchase or sale; such grants are common as compensation for executives and do not by themselves indicate buying or selling in the market.
• Because the award vests after 180 days, Jenkins cannot fully benefit from or exercise these options until the vesting date (subject to plan terms). The Form 4 excerpt did not list an exercise price or total post-transaction holdings in the provided data.